Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth. (Q39814340)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

title

Upregulation of lactate dehydrogenase A by ErbB2 through heat shock factor 1 promotes breast cancer cell glycolysis and growth (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

author name string

Y H Zhao

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

M Zhou

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

H Liu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

Y Ding

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

H T Khong

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

D Yu

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

O Fodstad

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

language of work or name

English

0 references

publication date

10 August 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

volume

28

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

issue

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

5 February 2020

page(s)

3689-3701

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19668225 AND SRC:MED&resulttype=core&format=json

Estrogen-dependent, tamoxifen-resistant tumorigenic growth of MCF-7 cells transfected with HER2/neu

5 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

The Warburg effect and its cancer therapeutic implications

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Oncogenic alterations of metabolism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Energy deregulation: licensing tumors to grow

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Glycolysis in cancer: a potential target for therapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Causes and consequences of increased glucose metabolism of cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Cancer cell metabolism: Warburg and beyond

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis and anchorage-independent growth.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Cancer's molecular sweet tooth and the Warburg effect.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Tumor cell metabolism: cancer's Achilles' heel

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

A hypoxia-independent hypoxia-inducible factor-1 activation pathway induced by phosphatidylinositol-3 kinase/Akt in HER2 overexpressing cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Transcriptional regulation of BRD7 expression by Sp1 and c-Myc

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to Taxol resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Selective suppression of lymphomas by functional loss of Hsf1 in a p53-deficient mouse model for spontaneous tumors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Delta protein kinase C interacts with the d subunit of the F1F0 ATPase in neonatal cardiac myocytes exposed to hypoxia or phorbol ester. Implications for F1F0 ATPase regulation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Glycolysis inhibition for anticancer treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Regulation of clock and NPAS2 DNA binding by the redox state of NAD cofactors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Activation of heat shock gene transcription by heat shock factor 1 involves oligomerization, acquisition of DNA-binding activity, and nuclear localization and can occur in the absence of stress

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Phosphorylation on tyrosine-15 of p34(Cdc2) by ErbB2 inhibits p34(Cdc2) activation and is involved in resistance to taxol-induced apoptosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Selective inhibition of ErbB2-overexpressing breast cancer in vivo by a novel TAT-based ErbB2-targeting signal transducers and activators of transcription 3-blocking peptide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

ErbB2 promotes Src synthesis and stability: novel mechanisms of Src activation that confer breast cancer metastasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Upregulation and activation of PKC alpha by ErbB2 through Src promotes breast cancer cell invasion that can be blocked by combined treatment with PKC alpha and Src inhibitors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Agonist-activated glucocorticoid receptor inhibits binding of heat shock factor 1 to the heat shock protein 70 promoter in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Heat shock response modulators as therapeutic tools for diseases of protein conformation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Untangling the ErbB signalling network

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

ErbB receptors: from oncogenes to targeted cancer therapies

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229

Cancer metabolism: facts, fantasy, and fiction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/ONC.2009.229